Pharmacogenomics HW 1 Notecards Flashcards

1
Q

What condition was covered in the homework?

A

Pancreatic adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are PD1 and PD-L1?

A

Biomarkers to determine if a certain patient is likely to benefit from immunotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When would you use PD1/PD-L1 blockers as treatment?

A

-If either of these biomarkers have increased expression in cancer

-If there is a very strong mismatched repair deficit (MMR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why do T cells not kill cancer cells?

A

Cancer cells express PD-L1 which interacts with PD-1 on T cells

*this sends signals to the T cell which makes it think that the cancer cell is a normal healthy cell

**this is why we want to either block PD-1 on the T cell or PD-L1 on the cancer cell, so this interaction does not occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where is PD-1 expressed?

A

T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where is PD-L1 expressed?

A

Cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Should a doctor order a test to check the PD1 or PD-L1 expression in a tumor sample?

A

PD-L1

(PD1 is not present in the tumor sample, found on T cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do PD1 levels tell us?

A

How many T cells have migrated to the cancer cells

**Does not affect clinical decision making because we do not know anything about what the cancer cells are expressing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do we decide whether to use a PD1 blocker or a PD-L1 blocker?

A

Look at clinical trials

-results can vary based on types of cancer, some respond better to certain blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does Avelumab (Bavencio) block?

A

PD-L1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does Durvalumab (Imfinzi) block?

A

PD-L1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does Pembrolizumab (Keytruda) block?

A

PD-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does Atezolizumab (Tecentriq) block?

A

PD-L1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does Nivolumab (Opdivo) block?

A

PD-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does Cemiplimab (Libtayo) block?

A

PD-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the PD-1 blockers?

A

Pembrolizumab (Keytruda)

Nivolumab (Opdivo)

Cemiplimab (Libtayo)

17
Q

What are the PD-L1 blockers?

A

Atezolizumab (Tecentriq)

Avelumab (Bavencio)

Durvalumab (Imfinzi)

18
Q

What drugs are used to treat cancer cells with BRCA1 mutations?

A

PARP inhibitors

19
Q

What are the PARP and BRCA-mediated pathways used for?

A

To repair DNA

20
Q

True or False: In BRCA-mutated cells, the PARP pathway still can occur

A

TRUE, but accuracy is low

21
Q

What is a problem with having both the BRCA and PARP pathways blocked?

A

Both DNA repair pathways are disrupted (neither one running)

**cell dies

22
Q

What is synthetic lethality?

A

UV light, sunlight, smoking, and other stress can cause a breakage of DNA

99% of time this can be fixed by repair mechanisms in the cell

**but this is a problem when DNA repair pathways are mutated (BRCA and PARP)

23
Q

What kind of DNA break is repaired by PARP?

A

Single-strand breaks

24
Q

What kind of DNA break is repaired by BRCA?

A

Double-strand breaks

*done through homologous recombination

25
Why are PARP and BRCA inhibitors effective?
Only cancer cells have the mutated PARP or BRCA so blocking these can lead to cancer cell death without affecting other cells
26
In cancer cells, are BRAC/PARP gain-of-function or loss-of-function mutations more common?
Loss-of-function *DNA not repaired, more mutations
27
True or False: KRAS therapy directly targets KRAS
False -target downstream proteins
28
What drugs target BRAC1?
Olaparib Niraparib Talazoparib Rucaparib
29
What drugs target KRAS?
Binimetinib Trametinib Cobimetinib
30
What pathways are activated by KRAS?
RAF-MEK pathway PI3K pathway **consider inhibitors for these
30
What KRAS mutation is targeted by AMG 510?
KRAS-G12C *note: in the homework they had G12V
31
What is CDKN2A?
Important cell surface protein that inhibits CDK4 and CDK6 which are important for cell proliferation! *without CDKN2A, there is nothing to inhibit cell proliferation
32
What is the function of CDK4 and CDK6?
Cell proliferation
33
When CDKN2A has a loss of function mutation, what do we do?
Need to artificially inhibit CDK4 and CDK6
34
What are the CDK4 and CDK6 inhibitors?
Palbociclib Ribociclib Abemaciclib
35
What combination therapy can be used in melanoma patients with NRAS mutations?
Ribociclib (Kisqali) + Binimetinib (Mektovi)